Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
Summary: We describe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cell responses, soluble markers of inflammation, and antibody levels and neutralization capacity longitudinally in 70 individuals with PCR-confirmed SARS-CoV-2 infection. Participants represent a spectrum of...
Main Authors: | Michael J. Peluso, Amelia N. Deitchman, Leonel Torres, Nikita S. Iyer, Sadie E. Munter, Christopher C. Nixon, Joanna Donatelli, Cassandra Thanh, Saki Takahashi, Jill Hakim, Keirstinne Turcios, Owen Janson, Rebecca Hoh, Viva Tai, Yanel Hernandez, Emily A. Fehrman, Matthew A. Spinelli, Monica Gandhi, Lan Trinh, Terri Wrin, Christos J. Petropoulos, Francesca T. Aweeka, Isabel Rodriguez-Barraquer, J. Daniel Kelly, Jeffrey N. Martin, Steven G. Deeks, Bryan Greenhouse, Rachel L. Rutishauser, Timothy J. Henrich |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Cell Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124721009487 |
Similar Items
-
Effect of Oral Nirmatrelvir on Long COVID Symptoms: 4 Cases and Rationale for Systematic Studies
by: Michael Peluso, et al.
Published: (2022-06-01) -
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations
by: Bing Sun, et al.
Published: (2021-02-01) -
Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in context
by: Ivan Chun Hang Lam, et al.
Published: (2023-06-01) -
Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection
by: Sonja H. Brunvoll, et al.
Published: (2023-01-01) -
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
by: Hector Bonilla, et al.
Published: (2023-03-01)